+ Filter



LCMV GP

Anti-LCMV GP Products
- Human Anti-LCMV GP Recombinant Antibody (HPAB-N0348-YC) (HPAB-N0348-YC)
-
- Species Reactivity: LCMV
- Type: Human IgG
- Application: ELISA, Neut
- PE-H-2Db/LCMV GP (CSANNSHHYI) MHC Tetramer (MHC-CN0969)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: CSANNSHHYI
- Conjugate: PE
- APC-H-2Db/LCMV GP (CSANNSHHYI) MHC Tetramer (MHC-CN0970)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: CSANNSHHYI
- Conjugate: APC
- FITC-H-2Db/LCMV GP (CSANNSHHYI) MHC Tetramer (MHC-CN0971)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: CSANNSHHYI
- Conjugate: FITC
- A*02:01/LCMV GP (SLNQTVHSL) MHC Tetramer (MHC-CN0984)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: SLNQTVHSL
- Conjugate: Unconjugated
- Recombinant Human Anti-LCMV GP Antibody (clone 18.5C-M28) (VS-0923-XY19)
-
- Species Reactivity: Lymphocytic choriomeningitis virus (LCMV)
- Type: Human IgG
- Application: ELISA, BLI, Neut
- APC-A*02:01/LCMV GP (YLVSIFLHL) MHC Tetramer (MHC-CN0978)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: YLVSIFLHL
- Conjugate: APC
- FITC-A*02:01/LCMV GP (YLVSIFLHL) MHC Tetramer (MHC-CN0979)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: YLVSIFLHL
- Conjugate: FITC
- A*02:01/LCMV GP (YLVSIFLHL) MHC Tetramer (MHC-CN0980)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: YLVSIFLHL
- Conjugate: Unconjugated
- PE-A*02:01/LCMV GP (SLNQTVHSL) MHC Tetramer (MHC-CN0981)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: SLNQTVHSL
- Conjugate: PE
- APC-A*02:01/LCMV GP (SLNQTVHSL) MHC Tetramer (MHC-CN0982)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: SLNQTVHSL
- Conjugate: APC
- FITC-A*02:01/LCMV GP (SLNQTVHSL) MHC Tetramer (MHC-CN0983)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: SLNQTVHSL
- Conjugate: FITC
- H-2Db/LCMV GP (CSANNSHHYI) MHC Tetramer (MHC-CN0972)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: CSANNSHHYI
- Conjugate: Unconjugated
- PE-A*02:01/LCMV GP (ALPHIIDEV) MHC Tetramer (MHC-CN0973)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: ALPHIIDEV
- Conjugate: PE
- APC-A*02:01/LCMV GP (ALPHIIDEV) MHC Tetramer (MHC-CN0974)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: ALPHIIDEV
- Conjugate: APC
- FITC-A*02:01/LCMV GP (ALPHIIDEV) MHC Tetramer (MHC-CN0975)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: ALPHIIDEV
- Conjugate: FITC
- A*02:01/LCMV GP (ALPHIIDEV) MHC Tetramer (MHC-CN0976)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: ALPHIIDEV
- Conjugate: Unconjugated
- PE-A*02:01/LCMV GP (YLVSIFLHL) MHC Tetramer (MHC-CN0977)
-
- Class: Class I
- Antigen: LCMV GP
- Antigen Species: LCMV
- Peptide: YLVSIFLHL
- Conjugate: PE
- Human Anti-LCMV GP Recombinant Antibody; scFv Fragment (HPAB-N0348-YC-S(P)) (HPAB-N0348-YC-S(P))
-
- Species Reactivity: LCMV
- Type: Human scFv
- Application: ELISA, Neut
- Human Anti-LCMV GP Recombinant Antibody; Fab Fragment (HPAB-N0348-YC-F(E)) (HPAB-N0348-YC-F(E))
-
- Species Reactivity: LCMV
- Type: Human Fab
- Application: ELISA, Neut
More Infomation
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
The mammarenavirus lymphocytic choriomeningitis virus (LCMV) is a globally distributed zoonotic pathogen that can be lethal in immunocompromised patients and can cause severe birth defects if acquired during pregnancy. The envelope glycoproteins of LCMV (LCMV GP) are initially expressed as a precursor polypeptide, GP-C, which is posttranslationally processed by a cellular protease into GP-1 and GP-2. GP-1 interacts with the cellular receptor for LCMV, which has been identified as alpha-dystroglycan. GP-2 contains the fusion peptide and the transmembrane domain.